Latest Blog Posts

FDA Announces Recall of Hair Loss Medication

by Staff Blogger | May 12th, 2020

According to a statement published by the U.S. Food and Drug Administration on May 11, 2020, 1 lot of Finasteride Plus 1.25 mg, a medication designed to treat hair loss, is being recalled by its manufacturer MasterPharm, LLC. The recall is due to the medication containing undeclared amounts of minoxidil, which exceed those found in

Read More

Where Can You Learn About Drug Recalls?

by Staff Blogger | May 5th, 2020

At Ferrer, Poirot & Wansbrough, it’s our job to help people harmed by defective and recalled medications get the compensation they deserve. But our years of experience has taught us that many patients aren’t aware that their medications have been recalled until it’s too late. Unfortunately, it’s not uncommon for drug recalls to be underreported,

Read More

3 Eye-Opening Statistics about Prescription Medications

by Staff Blogger | April 28th, 2020

Think of a health condition, disease, or illness. Chances are, whatever you came up with, no matter how obscure it is, there’s a prescription medication designed to treat it. The pharmaceutical industry is big, big business, both in America and worldwide. Prescription drugs treat conditions ranging from common colds and muscle aches to cancer and

Read More

What is NDMA and Why is It in Many Recalled Drugs?

by Staff Blogger | April 21st, 2020

On April 15, 2020, the U.S. Food and Drug Administration posted a notice on its website that a Nizatidine Oral Solution 15 mg/mL product was recalled due to containing high levels of nitrosodimenthylamine (NDMA). The product is manufactured by Amneal Pharmaceuticals, LLC, and distributed by its subsidiary Gemini Laboratories, LLC. NDMA is classified as a

Read More